Navigation Links
Prozac Reduces Disease Activity in MS Patients
Date:4/30/2008

Small study finds antidepressant cut inflammation in relapsing remitting illness

WEDNESDAY, April 30 (HealthDay News) -- Prozac may help reduce disease activity in people with the relapsing remitting form of multiple sclerosis (MS), a new study suggests.

Forty patients with the disease were randomly selected to receive either 20 milligrams a day of fluoxetine (Prozac) or a placebo for 24 weeks. MRI brain scans were conducted every four weeks to monitor the patients for new areas of neurological inflammation, a hallmark of disease activity.

Of the 38 patients (19 in each group) who completed the study, those who took the placebo had more new areas of inflammation (average of more than five areas) than those who took the drug (average of just under two).

One in four scans from patients treated with fluoxetine showed new areas of inflammation, compared with four out of 10 scans from patients taking the placebo. During the last 16 weeks of treatment, 63 percent of patients in the fluoxetine group had no new areas of inflammation, compared with 26 percent of those in the placebo group.

The findings were published online in the Journal of Neurology Neurosurgery and Psychiatry.

This was a small study, and larger studies are needed before any firm conclusions about the use of fluoxetine in patients with relapsing remitting MS can be made, the study authors noted.

However, the findings are "sufficiently encouraging to justify further studies with fluoxetine in patients with MS," they said, and added that higher doses and treatment combinations with other drugs that alter the immune response should be considered in future studies.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about multiple sclerosis.



-- Robert Preidt



SOURCE: BMJ Specialist Journals, news release, May 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Prozac Makes Old Brain Cells Young
2. Staff Training Reduces Postpartum Bleeding, Episiotomies
3. Gene Therapy in Rats Reduces Cocaine Use
4. Study shows pine bark naturally reduces osteoarthritis
5. Study Shows Pine Bark Naturally Reduces Osteoarthritis
6. Gene therapy reduces cocaine use in rats
7. Pill Reduces Relapses in MS Patients
8. Essential Nutrient Found in Eggs Reduces Risk of Breast Cancer by 24 Percent
9. Essential nutrient found in eggs reduces risk of breast cancer by 24 percent
10. Psychological intervention reduces postembolization pain
11. Aspirin Reduces Asthma Risk Among Older Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 2016 , ... Of the variety of ingredients in the food supply, few ... to common beliefs that hot dogs include “everything but the oink,” today’s wieners are ... combined with meat and poultry in a hot dog recipe can add flavor, keep ...
(Date:12/6/2016)... ... 06, 2016 , ... SPH Analytics recently ranked fifth on ... based on reported data for 2015 performance and recognizes SPHA for its top-tier ... integrated networks, and many of the nation’s leading health plans. , “In response ...
(Date:12/6/2016)... Texas (PRWEB) , ... December 06, 2016 , ... It ... best holiday presents for their four-legged family members as they do for their human ... lives, pet parents’ desire to find the highest quality and most innovative pet products ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... The NALA, ... the Teddy Bear Cancer Foundation (TBCF), a nonprofit 501(C)(3) organization providing financial ... and San Luis Obispo counties. To assist TBCF, the NALA recently hosted a Thanksgiving ...
(Date:12/6/2016)... ... December 06, 2016 , ... Public middle and ... 2017 to apply for a 2016/2017 California Casualty Thomas R. Brown Athletics Grant. ... schools can receive up to $3,000. , The grant is named after ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016 Breast Pump Market size is estimated ... by Global Market Insights, Inc. Continue Reading ... ... , , ... women employment rates and rising consumer awareness regarding importance of breast feeding will ...
(Date:12/6/2016)... , Dec. 6, 2016 /PRNewswire/ - InMed Pharmaceuticals, ... today on its R&D program in the use ... pulmonary disease (COPD). In June, 2015 InMed initiated ... to identify the targets and potential active compounds ... COPD. Subsequently, with in vitro assays using human ...
(Date:12/6/2016)... Dec. 6, 2016  BioAtla, LLC, a ... of Conditionally Active Biologic (CAB) antibody therapeutics, ... Group Company, Limited (Sinobioway) selected their first ... specific program candidates and the targeted indications ... and Sinobioway entered into a strategic collaboration ...
Breaking Medicine Technology: